InvestorsObserver
×
News Home

Premarket Mover: Royalty Pharma plc (RPRX) Up 2.26%

Monday, November 22, 2021 08:14 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Royalty Pharma plc (RPRX) Up 2.26%

Royalty Pharma plc (RPRX) is higher by Monday morning, with the stock adding 2.26% in pre-market trading to 42.5. RPRX's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, Royalty Pharma plc ranks higher than 84% of stocks. Royalty Pharma plc has risen 10.83% over the past month, closing at $37.67 on October 25. During this period of time, the stock fell as low as $36.81 and as high as $43.68. RPRX has an average analyst recommendation of Strong Buy. The company has an average price target of $51.71.

Overall Score - 54
RPRX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on RPRX!
Royalty Pharma plc has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, RPRX ranks better than 63% of stocks.

Important Dates for Investors in RPRX:

-Royalty Pharma plc is set to release earnings on 2/8/2022. During their last earnings release the company posted EPS of $1.94. -We do not have a set dividend date for Royalty Pharma plc at this time. Click Here To Get The Full Report on Royalty Pharma plc (RPRX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App